HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer

Acquired resistance to platinum (Pt)‐based therapies is an urgent unmet need in the management of epithelial ovarian cancer (EOC) patients. Here, we characterized by an unbiased proteomics method three isogenic EOC models of acquired Pt resistance (TOV‐112D, OVSAHO, and MDAH‐2774). Using this approa...

Full description

Saved in:
Bibliographic Details
Published in:Mol Oncol
Main Authors: Lombardi, Rita, Sonego, Maura, Pucci, Biagio, Addi, Laura, Iannelli, Federica, Capone, Francesca, Alfano, Luigi, Roca, Maria Serena, Milone, Maria Rita, Moccia, Tania, Costa, Alice, Di Gennaro, Elena, Bruzzese, Francesca, Baldassarre, Gustavo, Budillon, Alfredo
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2021
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8024727/
https://ncbi.nlm.nih.gov/pubmed/33331136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12883
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items